Karyopharm is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of blood cancer... Read more
Karyopharm is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of blood cancer... Read more
2008
PublicIndependent CompanyNASDAQKPTI
News
Apr 04, 2025
Vbngtv
Karyopharm Therapeutics: Karyopharm Announces 1-for-15 Reverse Stock Split
Feb 24, 2025
Insidertracking
Karyopharm Therapeutics: Karyopharm Announces 1-for-15 Reverse Stock Split
Feb 20, 2025
Yahoo
Karyopharm Therapeutics: Karyopharm Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Feb 20, 2025
Owler
Karyopharm Therapeutics, Inc.: Karyopharm Therapeutics's employee count changed from 325 in Feb 2024 to 279 in Dec 2024
Feb 19, 2025
Finanznachrichten
Karyopharm Therapeutics: Karyopharm Therapeutics Inc.: Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress
Feb 12, 2025
Usalifesciences
Karyopharm Therapeutics: Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
Jan 14, 2025
Investing
Karyopharm Therapeutics: Karyopharm Therapeutics' SWOT analysis: oncology firm's stock faces pivotal year
Jan 13, 2025
Marketscreener
Karyopharm Therapeutics: Karyopharm Therapeutics Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2024
Jan 13, 2025
Nasdaq
Karyopharm Therapeutics: Karyopharm Therapeutics Expects Q4 Revenues Of $30 Mln
Dec 15, 2024
Investing
Karyopharm Therapeutics: Karyopharm Therapeutics Inc.'s SWOT analysis: oncology firm's stock faces pivotal trials
Karyopharm Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10